Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
41.11
+0.39 (0.96%)
At close: Oct 15, 2026, 4:00 PM EDT
41.13
+0.02 (0.05%)
After-hours: Oct 15, 2026, 7:49 PM EDT
Teva Pharmaceutical Market Cap
Teva Pharmaceutical has a market cap or net worth of $47.91 billion as of October 15, 2026. It is the 516th most valuable company in the world and the 261st biggest in the United States. Its market cap has increased by 107.66% in one year.
Market Cap
47.91B
Enterprise Value
61.14B
1-Year Change
107.66%
Global Rank
Country Rank
#261 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Teva Pharmaceutical's market cap has increased from $6.10B to $47.91B, an increase of 685.09%. That is a compound annual growth rate of 7.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 47.91B | 33.79% |
| Dec 31, 2025 | 35.81B | 43.39% |
| Dec 31, 2024 | 24.97B | 113.39% |
| Dec 29, 2023 | 11.70B | 15.54% |
| Dec 30, 2022 | 10.13B | 14.65% |
| Dec 31, 2021 | 8.84B | -16.46% |
| Dec 31, 2020 | 10.58B | -1.18% |
| Dec 31, 2019 | 10.70B | -31.87% |
| Dec 31, 2018 | 15.71B | -18.33% |
| Dec 29, 2017 | 19.23B | -41.54% |
| Dec 30, 2016 | 32.90B | -41.16% |
| Dec 31, 2015 | 55.92B | 2.69% |
| Dec 31, 2014 | 54.45B | 43.98% |
| Dec 31, 2013 | 37.82B | 7.52% |
| Dec 31, 2012 | 35.17B | -7.04% |
| Dec 30, 2011 | 37.84B | -21.40% |
| Dec 31, 2010 | 48.14B | -3.59% |
| Dec 31, 2009 | 49.93B | 45.08% |
| Dec 31, 2008 | 34.41B | -6.66% |
| Dec 31, 2007 | 36.87B | 83.46% |
| Dec 29, 2006 | 20.10B | -25.46% |
| Dec 30, 2005 | 26.96B | 62.59% |
| Dec 31, 2004 | 16.58B | 13.05% |
| Dec 31, 2003 | 14.67B | 46.88% |
| Dec 31, 2002 | 9.99B | -51.34% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 59.75B |
| Haleon | 41.11B |
| Zoetis | 30.78B |
| United Therapeutics | 23.43B |
| Viatris | 19.89B |
| Neurocrine Biosciences | 13.83B |
| Elanco Animal Health | 11.12B |
| Dr. Reddy's Laboratories | 10.75B |